The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RANO 2.0: Proposal for an update to the Response Assessment in Neuro-Oncology (RANO) Criteria for high- and low-grade gliomas in adults.
 
Patrick Y. Wen
Consulting or Advisory Role - AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Boston Pharmaceuticals; Celularity; Chimerix; Day One Biopharmaceuticals; ElevateBio; Genenta Science; GlaxoSmithKline; Insightec; Integral Health; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Novocure; Novocure; Nuvation Bio; Prelude Therapeutics; Prelude Therapeutics; Sagimet Biosciences; Sapience Therapeutics; Servier; Servier; Vascular Biogenics; VBI Vaccines
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Celgene (Inst); Chimerix (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Oncoceutics (Inst); Puma Biotechnology (Inst); Servier (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Martin J. Van Den Bent
Employment - AstraZeneca (I)
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Boston Pharmaceuticals; carthera; chimerix; Genenta Science; Nerviano Medical Sciences
Research Funding - Abbvie (Inst)
 
Gilbert Youssef
No Relationships to Disclose
 
Timothy Francis Cloughesy
Stock and Other Ownership Interests - Chimerix; Katmai Pharmaceuticals; Notable Labs
Consulting or Advisory Role - Abbvie; Agios; Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; DelMar Pharmaceuticals; DNAtrix; Global Coalition for Adaptive Research; GW Pharmaceuticals; Inovio Pharmaceuticals; Karyopharm Therapeutics; Katmai Pharmaceuticals; KIYATEC; Merck; Novartis; Pascal Biosciences; Pfizer; QED Therapeutics; Roche/Genentech; Sapience Therapeutics; SERVIER; SonaCare Medical; Tocagen; VBI Vaccines; VBL Therapeutics
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No.: 62/819,322 Title: COMPOSITIONS AND METHODS FOR TREATING CANCER Filing Date: March 15, 2019 Inventor(s): David A. Nathanson et al. FH Reference No.: UCH-17760 (32246-17760) Your Reference No.: [UCLA 2019-630-1] US
Other Relationship - Break Through Cancer; Global Coalition for Adaptive Research
 
Benjamin M. Ellingson
Consulting or Advisory Role - Alpheus Medical; Chimerix; Ellipses Pharma; Global Coalition for Adaptive Research; Imaging Endpoints; ImmunoGenesis; Janssen; Kazia Therapeutics; Medicenna; MedQIA; Monteris Medical; Neosoma; SERVIER; Siemens; Sumitomo Dainippon Pharma Oncology; VBL Therapeutics
Research Funding - Janssen; Siemens
Travel, Accommodations, Expenses - Siemens
 
Michael Weller
Honoraria - Bayer; Novocure
Consulting or Advisory Role - Bayer (I); Curevac; Janssen (I); LEO Pharma (I); Medac; Novartis; Orbus Therapeutics; Philogen; Pierre Fabre (I); Roche; Sandoz; Seagen (I)
Research Funding - Quercegen Pharmaceuticals (Inst); Versameb (Inst)
 
Evanthia Galanis
Consulting or Advisory Role - Gradalis; Karyopharm Therapeutics (Inst); KIYATEC; MedImmune (Inst); SERVIER (Inst)
Research Funding - Celgene (Inst); MedImmune (Inst); SERVIER (Inst); TRACON Pharma (Inst)
 
Daniel Barboriak
No Relationships to Disclose
 
John Frederick de Groot
Employment - Alaunos Therapeutics (I); Brii Biosciences (I)
Stock and Other Ownership Interests - Alaunos Therapeutics (I); Brii Biosciences (I); WuXi Biologics
Consulting or Advisory Role - Agios; Aucentra Therapeutics; Bioasis Technologies; CarThera; Chimerix; Cure Brain Cancer Foundation; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Kintara Therapeutics; Merck; Midatech Pharma; Monteris Medical; Mundipharma Research; Samus Therapeutics; Sapience Therapeutics; Sumitomo Dainippon Pharma Oncology; VBI Vaccines
Research Funding - CarThera (Inst); Haihe Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - Chimerix; VBI Vaccines
 
Mark R. Gilbert
No Relationships to Disclose
 
Raymond Yi-kun Huang
Consulting or Advisory Role - Agios; Nuvation Bio; Nuvation Bio; Vysioneer
Research Funding - Agios; Bristol-Meyers-Squibb
 
Andrew B. Lassman
Honoraria - Clinical Education Alliance
Consulting or Advisory Role - Affinia Therapeutics; Aptitude Health; BioClinica; Chimerix; Elsevier; Karyopharm Therapeutics; Leal Therapeutics; Neuron-D; Novocure; Orbus Therapeutics; RadMD; Sapience Therapeutics; Vivacitas Oncology
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Bayer (Inst); Biohaven Pharmaceuticals (Inst); BMS (Inst); Chimerix (Inst); Corden (Inst); DelMar Pharmaceuticals (Inst); Genentech/Roche (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); NextSource (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst); Servier (Inst); VBI Vaccines (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Bridgebio; Chimerix; Karyopharm Therapeutics; MJH Healthcare Holdings, LLC; Northwestern University; Novartis; Pfizer; VBI Vaccines
 
Minesh P. Mehta
Stock and Other Ownership Interests - Chimerix
Consulting or Advisory Role - Kazia Therapeutics; Mevion Medical Systems; Novocure; Xoft; ZappRx
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY
(OPTIONAL) Uncompensated Relationships - ViewRay; Xcision Medical Systems
 
Annette Molinaro
No Relationships to Disclose
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; Tocagen
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche
 
Lalitha Krishna Shankar
No Relationships to Disclose
 
Wolfgang Wick
Consulting or Advisory Role - MSD Oncology (Inst); Roche/Genentech (Inst)
Research Funding - Apogenix (Inst); Pfizer (Inst); Roche (Inst)
 
David A. Reardon
Honoraria - Advantagene; Agenus; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Deciphera; DelMar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kintara Therapeutics; KIYATEC; Medicenna; Merck; Merck KGaA; NEUVOGEN; Novocure; Oncorus; Regeneron; Sumitono Dainippon Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Vivacitas Oncology; Y-mAbs Therapeutics
Consulting or Advisory Role - Advantagene; Agenus; Agios; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Kintara Therapeutics; Kiyatec; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical; Vivacitas Oncology
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Enterome (Inst); Incyte (Inst); Omniox
 
Michael A. Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Honoraria - Chimerix; Plus Therapeutics
Consulting or Advisory Role - Midatech Pharma; Olympus
Research Funding - Celgene (Inst); Denovo Biopharma (Inst); Infusion Therapeutics (Inst); Oncosynergy (Inst)
Patents, Royalties, Other Intellectual Property - Patents for drug delivery devices for the brain
 
Susan Marina Chang
Consulting or Advisory Role - AstraZeneca